Education
About Us
Working with TipRanks
Follow Us
Annovis Bio (ANVS)
NYSE:ANVS
Buntanetap/Posiphen
Alzheimer Disease
Phase II/III
Completed
A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate AD
Jan 06, 2023
―
Buntanetap/Posiphen
Parkinson's Disease, Idiopathic
Phase III
Completed
A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD
Apr 19, 2022
―
Posiphen
Alzheimer Disease, Parkinson Disease
Phase I/II
Completed
Posiphen® Dose-Finding, Biomarker Study in Early Alzheimer's and Parkinson's Patients
Aug 11, 2020
―
Posiphen
Alzheimer's Disease
Phase I/II
Completed
Safety, Tolerability, PK and PD of Posiphen® in Subjects With Early Alzheimer's Disease
Sep 29, 2016
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Annovis Bio (ANVS) have in its pipeline
ANVS is currently developing the following drugs: Buntanetap/Posiphen, Buntanetap/Posiphen, Buntanetap/Posiphen. These drug candidates are in various stages of clinical development as the company works toward FDA approval.